This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo


Ointment containing 5% lidocaine hydrochloride

Drugs List

  • lidocaine 5% ointment
  • Therapeutic Indications


    Local anaesthetic for topical use including surface anaesthesia of gums in dentistry.

    Pain relief from anal fissures, pruritis ani, pruritis vulvae, haemorrhoids, herpes zoster and herpes labialis.

    Symptomatic relief of sore nipples in nursing mothers

    As a lubricant in proctoscopy and cytoscopy.



    Dentistry: Apply to dry gum and rub gently

    Nursing mothers: Apply to the nipples using a small piece of gauze, wash off immediately before next feed.

    Other indications: Apply 1 to 2ml when required.


    See adult dose


    See adult dose

    Patients with Hepatic Impairment

    Use with caution in patients with severe hepatic impairment


    For topical administration


    Hypersensitivity to amide anaesthetics

    Precautions and Warnings

    Traumatised mucosa and/or sepsis in region of application as this will increase the systemic absorption of lidocaine.

    Oropharyngeal use may cause difficulty in swallowing increasing the possible danger of aspiration. Numbness of the tongue and buccal mucosa may also increase the chance of biting trauma.

    Local anaesthetics should be used with caution in patients with impaired cardiac conditions, bradycardia, hepatic insufficiency and epilepsy.

    First trimester of pregnancy ( See Pregnancy section)

    Not for aseptic techniques - not bactericidal

    Treatment of large areas for more than 3 days especially in young children is not recommended as it may lead to increased systemic toxicity.

    Pregnancy and Lactation


    First trimester of pregnancy use only if benefits outweigh potential risks

    The use of all medication in pregnancy should be avoided whenever possible; particularly in the first trimester. Non-drug treatments should also be considered. When essential, a medication with the best safety record over time should be chosen, employing the lowest effective dose for the shortest possible time. Polypharmacy should be avoided. Teratogens taken in the pre-embryonic period, often quoted as lasting until 14-17 days post-conception, are believed to have an all-or-nothing effect. Where drugs have a short half-life, and when the date of conception is certain, this may allow women to be reassured where drug exposure has occurred within this time frame. Further advice may be available from the UK National Teratology Information Service (NTIS) and through ToxBase, available via password on the internet ( ) or if this is unavailable at the backup site ( ).


    The amount of lidocaine excreted in breast milk is too small to be harmful.

    Neonates, infants born prematurely, those with low birth weight, those with an unstable gastrointestinal function or who have serious illnesses may require special consideration. For any infant, if a drug is prescribed to the nursing mother, it should be at the lowest practical dose and for the shortest time. When drug administration is unavoidable and breastfeeding is to continue, minimisation of exposure of the infant to the drug may sometimes be achieved by timing the maternal doses to just after a feeding episode. Infants exposed to drugs via breast milk should be monitored for unusual signs or symptoms. Interactions between the drug received by the infant from the mother's milk and medication prescribed for the infant should also be considered, for example, when the drug given to the infant may prevent metabolism of the drug received via breast milk.
    Specialist advice is available from the UK Drugs in Lactation Advisory Service at

    Effects on Ability to Drive and Operate Machinery

    None known

    Side Effects

    Hypersensitivity reactions
    Cardiac arrest


    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( ) or if this is unavailable at the backup site ( ).

    Shelf Life and Storage

    Store below 25 degrees C

    Further Information

    Last Full Review Date: October 2010

    Reference Sources

    British National Formulary, 60th Edition (2010) Pharmaceutical Press, London.

    BNF for Children (2010-2011) Pharmaceutical Press, London.

    Martindale: The Complete Drug Reference, 36th edition (2009) ed. Sweetman, S. Pharmaceutical Press, London.

    Summary of Product Characteristics: Lidocaine ointment. Teva. Revised February 2009

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.